Merck Thyroid History
 
  Merck is one of the oldest, still operating chemical and pharmaceutical companies in the world. Its roots go back to the year 1668, when F.J. Merck purchased the Engel-Apotheke in Darmstadt. In 1827, E. Merck started with the large-scale production of alkaloids and later with plant extracts and many other chemicals. The products were manufactured with a standardized quality. The sales increased very fast, products were exported to countries all over the world and subsidiaries were formed in strategic locations.

In 1894, E. Merck introduced one of the first thyroid preparations in the world . Since then, E. Merck has played a substantial role in thyroid research and development:

 

1894

Thyroidinum siccatum
Introduction of desiccated sheep thyroid gland (powder, later tablets) in Germany. Available as Thyroidin Merck until 1983

1896

Thyroidin Merck (USA)
Offered in the price list published in Merck's 1896 Index (New York)

1901

Antithyroidin Merck
Produced from the serum of thyrectomized rams (Moebius)

1911

Glandula Thyroideae siccate "Merck" Tabletten
Dessiccated thyroid gland available as tablets

1912

Research on a standardized thyroid extract product
(Annual report Scientific Laboratory 1912)

1921

Thyreoidinum depurat. Notkin Tabletten
Thyroid protein extract

1925

Evaluation of Kendall's Thyroxine
"Obviously thyroxine is not the only active thyroid product"

1925

Thyroidea Opton
Introduction of protein-free degradation product of the thyroid gland

1928

Novothyral
Introduction of water soluble standardized thyroid extract (Axolotl)

1941

Thyroidin Merck
Standardized also with Axolotl method

1948

Methicil
Brand of Methylthiouracil available from Merck in Germany

1965

Kalium jodatum Compretten (100 mg KI)
Indicated for prevention of radioactive iodine incorporporation in nuclear accidents

1968

Novothyral
Newly introduced as a T3/T4 combination in Germany

1973

Euthyrox
Mono T4 tablets introduced in Germany, later in many other countries

1975

Jodid Merck
KI 100 mcg tablets (later 200 and 500 mcg) introduced in Germany

1985

Jodthyrox
T4/Iodide combination introduced in Germany for iodine deficiency goiter

1990

Thyrozol
Thiamazol (Methimazol) introduced in Germany

1993

Globalization of Merck KGaA's Thyroid business
.

The thyroid products of Merck KGaA, Darmstadt, Germany, are marketed all over the world, from France to Vietnam, from Russia to Chile. The products range from T4, T4/T3 combinations, iodine, T4/iodine combinations and Methimazole, as well as thyroid diagnostics, such as a TRH test, ThyroChek or Rapid Urinary Iodine Test.

Merck KGaA conducts thyroid research and supports thyroid researchers worldwide:

  • Exploring new concepts of pharmacokinetic studies.
  • Developing a rapid urinary iodine test for developing countries.
  • Organizing large epidemiological investigations.
  • Conducting clinical trials on their own thyroid products.
  • Supporting clinical trials of third parties in the thyroid field.
  • Granting thyroid research monies.
  • Sponsoring scientific meetings and associations.

Merck KGaA is also deeply involved in the development of patient information programs and physician postgraduate services.